Search

everythinglearnresearchcommunity

for

Search:↓

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

SHBG may be a useful early indicator and treatment target for PCOS.

Testosterone therapy in transgender men can cause acne.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Parathyroid hormone-related protein helps control hair growth phases in mice.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Minoxidil helps some bald men, but most lose hair again when stopping.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

A new skin treatment using a patient's own cells healed chronic wounds effectively and was preferred over traditional grafts.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Certain hormone treatments can improve acne and related conditions in women.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

CD98hc's role in skin health decreases with age.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Early detection of specific skin lesions can help identify Birt-Hogg-Dube syndrome and prevent serious complications.